Cargando…
Metformin prevents aggressive ovarian cancer growth driven by high-energy diet: similarity with calorie restriction
Caloric restriction (CR) was recently demonstrated by us to restrict ovarian cancer growth in vivo. CR resulted in activation of energy regulating enzymes adenosine monophosphate activated kinase (AMPK) and sirtuin 1 (SIRT1) followed by downstream inhibition of Akt-mTOR. In the present study, we inv...
Autores principales: | Al-Wahab, Zaid, Mert, Ismail, Tebbe, Calvin, Chhina, Jasdeep, Hijaz, Miriana, Morris, Robert T., Ali-Fehmi, Rouba, Giri, Shailendra, Munkarah, Adnan R., Rattan, Ramandeep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484428/ https://www.ncbi.nlm.nih.gov/pubmed/25895126 |
Ejemplares similares
-
Folic acid tagged nanoceria as a novel therapeutic agent in ovarian cancer
por: Hijaz, Miriana, et al.
Publicado: (2016) -
Dietary energy balance modulates ovarian cancer progression and metastasis
por: Al-Wahab, Zaid, et al.
Publicado: (2014) -
Metformin limits the adipocyte tumor-promoting effect on ovarian cancer
por: Tebbe, Calvin, et al.
Publicado: (2014) -
Metformin: An Emerging New Therapeutic Option for Targeting Cancer Stem Cells and Metastasis
por: Rattan, Ramandeep, et al.
Publicado: (2012) -
Bioenergetic Adaptations in Chemoresistant Ovarian Cancer Cells
por: Dar, Sajad, et al.
Publicado: (2017)